Stargardt Disease Clinical Trials in Gainesville, Florida

4 studies are recruiting for stargardt disease in Gainesville, Florida right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Study of ALK-001 on the Progression of Stargardt Disease

    This study evaluates the efficacy and safety of investigational study drug ALK-001 in participants 8 to 45 years of age, inclusive, with symptoms and signs of autosomal recessive Stargardt disease (STGD)

    Stage
    Phase 3
    Ages
    8 to 45
    Site
    Vitreo Retinal Associates, Gainesville, Florida
    Locations
    14 in total
    Run by
    Alkeus Pharmaceuticals, Inc.

    See if you can join NCT07419334 on ClinicalTrials.gov

  2. Prescreening Study to Identify Potential Stargardt Participants for ACDN-01 Clinical Trials (STARPATH)

    This is an observational prescreening study. Individuals who are eligible for prescreening will undergo testing procedures that may be used to determine eligibility in ACDN-01 clinical trials.

    Stage
    Not phased
    Ages
    5 and older
    Site
    Vitreo Retinal Associates, Gainesville, Florida
    Locations
    8 in total
    Run by
    Ascidian Therapeutics, Inc

    See if you can join NCT06445322 on ClinicalTrials.gov

  3. Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR)

    This study is an open-label, single ascending dose clinical trial in participants who have ABCA4-related retinopathies. This is the first-in-human clinical trial in which ACDN-01 will be evaluated for safety, tolerability, and preliminary efficacy following a single subretinal injection of ACDN-01.

    Stage
    Phase 1
    Ages
    12 and older
    Site
    Vitreo Retinal Associates, Gainesville, Florida
    Locations
    10 in total
    Run by
    Ascidian Therapeutics, Inc

    See if you can join NCT06467344 on ClinicalTrials.gov

  4. An Observational Study in Subjects to Follow the Progression of Stargardt Disease Type 1 (STGD1) Caused by Bi-Allelic Autosomal Recessive Mutations in the ABCA4 Gene

    This is an Observational Study to Follow the Progression of Stargardt Disease Type 1 (STGD1) Caused by Bi-Allelic Autosomal Recessive Mutations in the ABCA4 Gene This is a multicenter study which will enroll approximately 75 subjects

    Stage
    Not phased
    Ages
    12 to 65
    Site
    Vitreo Retinal Associates, Gainesville, Florida
    Locations
    20 in total
    Run by
    Splice Bio

    See if you can join NCT06435000 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.